These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4408941)

  • 21. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 22. Epistaxis secondary to oral contraceptive.
    Man A; Segal S
    Acta Otolaryngol; 1981; 92(3-4):383-4. PubMed ID: 7324906
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Our experiences with the long-term use of the oral low-dosage contraceptive Bisecurin].
    Marjanović M; Berić BM
    Med Pregl; 1975; 28(9-10):425-7. PubMed ID: 1186615
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 27. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J
    Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood platelet biochemistry in women receiving steroid contraceptives.
    Briggs M
    Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemodynamic effects of low doses of female sex steroids.
    Walters WA; Cain D
    Aust N Z J Obstet Gynaecol; 1973 Nov; 13(4):213-8. PubMed ID: 4615701
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral contraception using the "weekbypill" Depositon].
    Göretzlehner G; Rudolf K; Klausch B
    Zentralbl Gynakol; 1974 Dec; 96(50):1569-76. PubMed ID: 4456907
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of ovulation time with steroid and nonsteroid compounds.
    Boutselis JG; Dickey RP; Vorys N
    Am J Obstet Gynecol; 1972 Jan; 112(2):171-7. PubMed ID: 4333405
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of ampicillin on oral contraceptive effectiveness.
    Friedman CI; Huneke AL; Kim MH; Powell J
    Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.
    Forleo R; Vegna G; Pala A
    Acta Eur Fertil; 1972 Jun; 3(2):159-76. PubMed ID: 4679575
    [No Abstract]   [Full Text] [Related]  

  • 38. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G
    Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual patterns under hormonal contraception in adolescent girls and young women.
    Heinz M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():146-9. PubMed ID: 16641849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
    Jacobs C; Heinen G; Schmal E
    Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.